Semanteon Capital Management, LP Ocular Therapeutix, Inc Transaction History
Semanteon Capital Management, LP
- $157 Billion
- Q1 2024
A detailed history of Semanteon Capital Management, LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Semanteon Capital Management, LP holds 39,122 shares of OCUL stock, worth $307,107. This represents 0.23% of its overall portfolio holdings.
Number of Shares
39,122Holding current value
$307,107% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
149Shares Held
123MCall Options Held
185KPut Options Held
507K-
Summer Road LLC West Palm Beach, FL14.4MShares$113 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$100 Million9.97% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$99.9 Million3.82% of portfolio
-
Black Rock Inc. New York, NY8.06MShares$63.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.24MShares$56.8 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $604M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...